ADC Therapeutics (ADCT) Price to Book (2020 - 2026)

ADC Therapeutics has disclosed Price to Book across 7 years of filings, most recently posting 0.6 for Q2 2026.

• In Q2 2026, Price to Book rose 60.52% year-over-year to 0.6; the TTM figure through Jun 2026 stood at 0.6 (up 60.52% YoY), while the FY2025 annual figure was 2.39, down 146.04% from the prior year.
• Price to Book came in at 0.6 for Q2 2026 at ADC Therapeutics, up from 2.2 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 6.94 in Q1 2022 to a low of 9.72 in Q2 2023.
• Average Price to Book over 5 years is 0.34, with a median of 1.25 recorded in 2023.
• Year-over-year, Price to Book tumbled 283.6% in 2023 and surged 76.18% in 2024.
• Over 5 years, Price to Book stood at 3.9 in 2022, then plunged by 123.64% to 0.92 in 2023, then decreased by 5.36% to 0.97 in 2024, then plunged by 146.04% to 2.39 in 2025, then soared by 74.98% to 0.6 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 0.6 in Q2 2026, 2.2 in Q1 2026, and 2.39 in Q4 2025.